Thursday, 20 May 2010

Ezetimibe




In the US, Ezetimibe (ezetimibe systemic) is a member of the drug class cholesterol absorption inhibitors and is used to treat High Cholesterol, High Cholesterol - Familial Heterozygous and Sitosterolemia.

US matches:

  • Ezetimibe

  • Ezetimibe/Simvastatin

  • Ezetimibe and simvastatin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AX09

CAS registry number (Chemical Abstracts Service)

0163222-33-1

Chemical Formula

C24-H21-F2-N-O3

Molecular Weight

409

Therapeutic Category

Antilipemic agent, cholesterol absorption inhibitor

Chemical Names

[3R,4S]-1-[p-Fluorophenyl]-3-[[3S]-3-[p-fluorophenyl]-3-hydroxypropyl]-4-[p-hydroxyphenyl]-2-azetidinone (WHO)

2-Azetidinone, 1-[4-fluorophenyl]-3-[3-[4-fluorophenyl]-3-hydroxypropyl]-4-[4-hydroxyphenyl]-, [3R-[3[S*],4]]- (USAN)

Foreign Names

  • Ezetimibum (Latin)
  • Ezetimib (German)
  • Ezetimibe (French)
  • Ezetimiba (Spanish)

Generic Name

  • Ezetimibe (OS: USAN, BAN)

Brand Names

  • Acotral
    Phoenix, Argentina


  • Alin
    Lazar, Argentina


  • Alipas
    Laboratorios, Argentina


  • Atorvik-EZ (Ezetimibe and Atorvastatin)
    Anvik, India


  • Avascare-EZ (Ezetimibe and Calcium Atorvastatin)
    Q-Check, India


  • Cerclerol
    Beta, Argentina


  • Coracil
    Gador, Argentina


  • Corexel
    Novartis, Argentina


  • Ezator (Ezetimibe and Atorvastatin)
    Farmindustria, Peru


  • Ezentia
    Sun, Myanmar


  • Ezeta
    Beximco, Bangladesh


  • Ezetib
    Unichem, India


  • Ezetim
    Incepta, Bangladesh


  • Ezetimibe-MSD
    Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, Luxembourg


  • Ezetrol
    Combiphar, Netherlands; Delphi, Netherlands; Dr. Fisher, Netherlands; Essex, Germany; Euro, Netherlands; Medcor, Netherlands; Merck, Czech Republic; Merck Frosst, Canada; Merck Sharp & Dhome, Oman; Merck Sharp & Dohme, Netherlands Antilles; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Aruba; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Barbados; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Bahrain; Merck Sharp & Dohme, Bahamas; Merck Sharp & Dohme, Belize; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, China; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, Ecuador; Merck Sharp & Dohme, Estonia; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, France; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Jamaica; Merck Sharp & Dohme, Cayman Islands; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Luxembourg; Merck Sharp & Dohme, Latvia; Merck Sharp & Dohme, Malta; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Serbia; Merck Sharp & Dohme, Russian Federation; Merck Sharp & Dohme, Sweden; Merck Sharp & Dohme, Singapore; Merck Sharp & Dohme, Slovenia; Merck Sharp & Dohme, Slovakia; Merck Sharp & Dohme, Turkey; Merck Sharp & Dohme, Trinidad & Tobago; Merck Sharp & Dohme, Taiwan; Merck Sharp & Dohme, Venezuela; Merck Sharp & Dohme, South Africa; Merck Sharp & Dome, Dominican Republic; MSD, Switzerland; MSD, Denmark; MSD, Finland; MSD, Georgia; MSD, Peru; MSD-SP, United Kingdom; MSD-SP, Ireland; MSD-SP, Norway; Schering-Plough, Belgium; Schering-Plough, Indonesia; Schering-Plough, Malaysia; Schering-Plough, Philippines; Schering-Plough, Russian Federation; Schering-Plough, Sweden; Schering-Plough, Singapore; Schering-Plough, Thailand; Vianex / BIANEΞ, Greece


  • Ezitoget
    Getz Pharma, Vietnam


  • Goltor (Ezetimibe and Simvastatin)
    Merck Sharp & Dohme, Germany


  • InductOs
    Wyeth, Slovenia


  • Inegy (Ezetimibe and Simvastatin)
    Combiphar, Netherlands; Dr. Fisher, Netherlands; Eureco, Netherlands; Euro, Netherlands; Medcor, Netherlands; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Bulgaria; Merck Sharp & Dohme, Bulgaria; Merck Sharp & Dohme, Bahrain; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, France; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Ireland; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Malta; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, Sweden; MSD, Switzerland; MSD, Denmark; MSD-SP, United Kingdom; MSD-SP, Norway; Schering-Plough, Hungary; Vianex / BIANEΞ, Greece


  • Ixacor
    Roemmers, Argentina


  • Nalecol
    Casasco, Argentina


  • Sinterol
    Klonal, Argentina


  • Trilip
    Elea, Argentina


  • Vadel
    Ivax, Argentina


  • Viemm
    Merck Sharp & Dohme, Germany


  • Visvas-EZ (Ezetimibe and Atorvastatin)
    Minova, India


  • Vytorin (Ezetimibe and Simvastatin)
    Merck / Schering-Plough, United States; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Singapore; Schering-Plough, Indonesia; Schering-Plough, Thailand


  • Zeklen (Ezetimibe and Simvastatin)
    Merck Sharp & Dohme, Germany


  • Zetia
    Merck, United States; Merck / Schering-Plough, United States; Plough, Colombia; Schering, United States; Schering-Plough, Argentina; Schering-Plough, Brazil; Schering-Plough, Costa Rica; Schering-Plough, Dominican Republic; Schering-Plough, Guatemala; Schering-Plough, Japan; Schering-Plough, Nicaragua; Schering-Plough, Panama; Schering-Plough, Peru; Schering-Plough, El Salvador; Schering-Plough, Venezuela


  • Zient
    Essex, Chile; Essex, Ecuador; Merck Sharp & Dohme, Germany; Schering-Plough, Mexico; Schering-Plough, Venezuela

International Drug Name Search

Glossary

BANBritish Approved Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment